A detailed history of Rfp Financial Group LLC transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Rfp Financial Group LLC holds 41,450 shares of CYDY stock, worth $4,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,450
Holding current value
$4,974
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$0.12 - $0.17 $4,974 - $7,046
41,450 New
41,450 $6,000

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $97.6M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Rfp Financial Group LLC Portfolio

Follow Rfp Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfp Financial Group LLC with notifications on news.